CG Oncology (CGON) Income Statement: Revenue & Earnings

CG Oncology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

CG Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	1.14	0.20	0.19	10.36
Cost of Revenue	0.00	45.75	29.03	18.32
Gross Profit	1.14	-45.55	-28.84	-7.96
Operating Expenses
Research & Development	82.10	45.75	29.03	18.32
Selling, General & Administrative	33.70	9.90	6.41	4.65
Operating Expenses	115.81	55.65	6.41	4.65
Operating Income	-114.67	-55.45	-35.25	-12.61
Other Income/Expense
Interest Income	26.62	6.90	1.60	0.00
Interest Expense	0.00	0.00	0.00	-0.45
Other Income/Expense	26.63	-0.06	-1.80	-0.18
Income
Income Before Tax	-88.04	-48.61	-35.44	-12.84
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-88.04	-48.61	-35.44	-12.84
Net Income - Continuous Operations	-88.04	-48.61	-35.44	-12.84
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-114.63	-55.43	-35.23	-12.60
EBIT	-88.04	-55.45	-35.25	-12.61
Depreciation & Amortization	0.03	0.02	0.02	0.01
Earnings Per Share
Basic EPS	-1.00	-1.00	-12.00	-5.00
Diluted EPS	-1.00	-1.00	-12.00	-5.00
Basic Shares Outstanding	62.50	63.48	3.74	3.65
Diluted Shares Outstanding	62.50	63.48	3.74	3.65